The past 18 months has presented the generics and brand pharmaceutical industries with a dilemma unique to the US market: whether a partnership to launch and market a generic version of the brand's ...

A federal appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic version of its blockbuster heart failure drug Entresto. The US Court of Appeals for ...

Every conversation I have with enterprise leaders today carries an unmistakable urgency about AI transformation. The economics have changed, possibilities have expanded dramatically, and the pressure ...

In another move designed to reduce the US' reliance on imported medicines, the FDA has launched a pilot of fast-track reviews for generics tested and made in domestic facilities. According to the ...